Egide (ALGID) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
10 Sep, 2025Executive summary
2024 consolidated revenue was €31.07M, a 15.5% decrease year-over-year, following an 8.7% increase in 2023.
Decline attributed to reduced orders from key customers, inventory and manufacturing issues, and supply chain disruptions.
Strategic investments and customer diversification continued, with positive momentum expected for 2025.
Financial highlights
Egide SA revenue fell by €2.77M (-15.8%), Egide USA by €2.52M (-21.7%), and Santier by €0.39M (-5.1%).
First half 2024 revenue was €15.43M, rising slightly to €15.64M in the second half, but still below H2 2023 (€17.56M).
At constant exchange rates, 2024 revenue would have been €30.03M.
Outlook and guidance
Single-digit revenue growth expected in 2025, driven by diversification and new applications in Defense and Aerospace.
Growth to be supported by modernization of industrial tools and expansion in thermal batteries and firing systems.
Latest events from Egide
- 2025 revenue rose 4% to €31.34m, driven by thermal imaging and European market gains.ALGID
H2 2025 TU26 Jan 2026 - EBITDA turned positive as revenue rose 1%, but net loss widened due to Santier’s downturn.ALGID
H1 202522 Oct 2025 - Thermal imaging and European growth drove a return to revenue expansion in H1 2025.ALGID
H1 2025 TU30 Jul 2025 - H1 2024 sales dropped 19%, but a €1.8M capital increase aims to support future growth.ALGID
H1 202413 Jun 2025 - 2024 revenue fell 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 2024 TU6 Jun 2025